Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter November 28, 2005


  • Tade Matthias Spranger


In their fundamental overview on intellectual property and biotechnology, Victoria Jimenez and Dennis Fernandez not only deal with the top-10 most common intellectual property rights mistakes during venture capital due diligence, but also present a basic analysis of IP strategy in biotech. The article also discusses IP problems related to genomics, proteomics, pharmacogenomics, bioinformatics, biochips, and, last but not least, emerging technologies such as nanotechnology or biogenerics, and therefore provides an ideal tool for all those who are interested in the role of intellectual property in the field of biotech.

Published Online: 2005-11-28
Published in Print: 2005-11-25

Walter de Gruyter GmbH & Co. KG

Downloaded on 28.9.2023 from
Scroll to top button